Clinical Significance of the Champagne Bottle Neck Sign in the Extracranial Carotid Arteries of Patients with Moyamoya Disease

References

1. 1.↵
   2. Suzuki J,
   3. Takaku A

   . Cerebrovascular “Moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99 doi:10.1001/archneur.1969.00480090076012 pmid:5775283

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Yang SH,
   3. Li B,
   4. Wang CC, et al

   . Angiographic study of Moyamoya disease and histological study in the external carotid artery system. Clin Neurol Neurosurg 1997;99:S61–63 doi:10.1016/S0303-8467(97)00035-8 pmid:9409408

   CrossRefPubMed
3. 3.↵
   2. Yasaka M,
   3. Ogata T,
   4. Yasumori K, et al

   . Bottle neck sign of the proximal portion of the internal carotid artery in Moyamoya disease. J Ultrasound Med 2006;25:1547–52 pmid:17121949

   Abstract/FREE Full Text
4. 4.↵
   2. Yasuda C,
   3. Yakusiji Y,
   4. Eriguchi M, et al

   . Usefulness of carotid ultrasonography for the early detection of Moyamoya disease [in Japanese]. Rinsho Shinkeigaku 2007;47:441–43 pmid:17710890

   PubMed
5. 5.↵
   2. Shimogawa T,
   3. Morioka T,
   4. Sayama T, et al

   . Champagne bottle neck sign in a patient with Moyamoya syndrome. World J Clin Cases 2014;2:474–77 doi:10.12998/wjcc.v2.i9.474 pmid:25232554

   CrossRefPubMed
6. 6.↵
   2. Fukui M

   . Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘Moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997;99:S238–40 doi:10.1016/S0303-8467(97)00082-6 pmid:9409446

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Nakagawara J,
   3. Takeda R,
   4. Suematsu K, et al

   . Quantification of regional cerebral blood flow and vascular reserve in childhood Moyamoya disease using [123I]IMP-ARG method. Clin Neurol Neurosurg 1997;99:S96–99 doi:10.1016/S0303-8467(97)00065-6 pmid:9409415

   CrossRefPubMed
8. 8.↵
   2. Saito N,
   3. Nakagawara J,
   4. Nakamura H, et al

   . Assessment of cerebral hemodynamics in childhood Moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study. Ann Nucl Med 2004;18:323–31 doi:10.1007/BF02984471 pmid:15359926

   CrossRefPubMed
9. 9.↵
   2. Honda M,
   3. Ezaki Y,
   4. Kitagawa N, et al

   . Quantification of the regional cerebral blood flow and vascular reserve in Moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. Surg Neurol 2006;66:155–59; discussion 159 doi:10.1016/j.surneu.2005.08.022 pmid:16876609

   CrossRefPubMed
10. 10.↵
    2. Fukui M,
    3. Kono S,
    4. Sueishi K, et al

    . Moyamoya disease. Neuropathology 2000;20:S61–64 pmid:11037190

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Ikeda E

    . Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke 1991;22:1358–62 doi:10.1161/01.STR.22.11.1358 pmid:1750042

    Abstract/FREE Full Text
12. 12.↵
    2. Kaczorowska M,
    3. Jozwiak S,
    4. Litwin M, et al

    . Moyamoya disease associated with stenosis of extracranial arteries: a case report and review of the literature. [in Polish] Neurol Neurochir Pol 2005;39:242–46 pmid:15981166

    PubMed
13. 13.↵
    2. Lee JH,
    3. Youn TJ,
    4. Yoon YE, et al

    . Coronary artery stenosis in Moyamoya disease: tissue characterization by 256-slice multi-detector CT and virtual histology. Circulation 2013;127:2063–65 doi:10.1161/CIRCULATIONAHA.112.136473 pmid:23690454

    FREE Full Text
14. 14.↵
    2. Hori E,
    3. Hayashi N,
    4. Hamada H, et al

    . A development of atheromatous plaque is restricted by characteristic arterial wall structure at the carotid bifurcation. Surg Neurol 2008;69:586–90; discussion 590–91 doi:10.1016/j.surneu.2007.05.033 pmid:18261781

    CrossRefPubMed
15. 15.↵
    2. Janzen J,
    3. Lanzer P,
    4. Rothenberger-Janzen K, et al

    . Variable extension of the transitional zone in the medial structure of carotid artery tripod. Vasa 2001;30:101–06 doi:10.1024/0301-1526.30.2.101 pmid:11417279

    CrossRefPubMed
16. 16.↵
    2. Grubb RL,
    3. Derdeyn CP,
    4. Fritsch SM, et al

    . Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055–60 doi:10.1001/jama.280.12.1055 pmid:9757852

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Yamauchi H,
    3. Higashi T,
    4. Kagawa S, et al

    . Is misery perfusion still a predictor of stroke in symptomatic major cerebral artery disease? Brain 2012;135:2515–26 doi:10.1093/brain/aws131 pmid:22637544

    Abstract/FREE Full Text
18. 18.↵
    2. Kang KH,
    3. Kim HS,
    4. Kim SY

    . Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation. AJNR Am J Neuroradiol 2008;29:1487–93 doi:10.3174/ajnr.A1129 pmid:18499785

    Abstract/FREE Full Text
19. 19.↵
    2. Kuriyama S,
    3. Kusaka Y,
    4. Fujimura M, et al

    . Prevalence and clinicoepidemiological features of Moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008;39:42–47 doi:10.1161/STROKEAHA.107.490714 pmid:18048855

    Abstract/FREE Full Text
20. 20.↵
    2. Ryoo S,
    3. Cha J,
    4. Kim SJ, et al

    . High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke 2014;45:2457–60 doi:10.1161/STROKEAHA.114.004761 pmid:24947295

    Abstract/FREE Full Text